# Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy

> **NCT01388777** · PHASE2 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 1 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Visica 2™ Treatment System
- **PROCEDURE:** Cryoablation
- **PROCEDURE:** Surgical Resection

## Key facts

- **NCT ID:** NCT01388777
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01-24
- **Primary completion:** 2017-06-14
- **Final completion:** 2017-06-14
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Early termination leading to small number of subjects analyzed
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01388777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01388777, "Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01388777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*